Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel via TAP block vs local infiltration in laparoscopic colorectal surgery
NCT03927326Unknown
- Sponsor
- University of Washington
- Start
- Aug 2019
- Primary completion
- Jul 2020
01
Overview
Randomised, open-label trial of bupivacaine in postoperative pain, sponsored by University of Washington. Primary endpoint: 24 hour post operative opioid consumption. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03927326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03927326.